Schonfeld Strategic Advisors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-203,680
| Closed | -$4.11M | – | 2693 |
|
|
2021
Q3 | $4.11M | Buy |
203,680
+158,795
| +354% | +$3.2M | 0.04% | 445 |
|
|
2021
Q2 | $1.68M | Buy |
44,885
+8,883
| +25% | +$331K | 0.02% | 734 |
|
|
2021
Q1 | $920K | Buy |
36,002
+21,064
| +141% | +$538K | 0.01% | 896 |
|
|
2020
Q4 | $330K | Sell |
14,938
-44,806
| -75% | -$990K | ﹤0.01% | 1137 |
|
|
2020
Q3 | $1.08M | Buy |
59,744
+36,312
| +155% | +$653K | 0.02% | 645 |
|
|
2020
Q2 | $595K | Buy |
+23,432
| New | +$595K | 0.02% | 704 |
|
|
2020
Q1 | – | Sell |
-10,036
| Closed | -$221K | – | 1640 |
|
|
2019
Q4 | $221K | Sell |
10,036
-35,864
| -78% | -$790K | 0.01% | 1126 |
|
|
2019
Q3 | $659K | Sell |
45,900
-117,800
| -72% | -$1.69M | 0.02% | 571 |
|
|
2019
Q2 | $2.58M | Buy |
+163,700
| New | +$2.58M | 0.09% | 249 |
|
|
2019
Q1 | – | Sell |
-85,900
| Closed | -$918K | – | 1363 |
|
|
2018
Q4 | $918K | Sell |
85,900
-192,400
| -69% | -$2.06M | 0.04% | 497 |
|
|
2018
Q3 | $4.25M | Buy |
278,300
+233,300
| +518% | +$3.56M | 0.19% | 154 |
|
|
2018
Q2 | $551K | Sell |
45,000
-51,268
| -53% | -$628K | 0.03% | 519 |
|
|
2018
Q1 | $921K | Buy |
+96,268
| New | +$921K | 0.07% | 339 |
|